Search results
Results From The WOW.Com Content Network
In 2015, Dr. Reddy's Laboratories bought the established brands of Belgian drugmaker UCB SA in South Asia for ₹ 8 billion ($128.38 million). [9] Dr. Reddy's Laboratories also signed a licensing pact with XenoPort for their experimental treatment to treat plaque psoriasis. As per the agreement, Dr. Reddy's will be granted exclusive US rights ...
Reddy and his family established the Prem Reddy Family Foundation, which has supported several efforts, including one of country's newest schools of medicine at the California University of Science and Medicine, the Dr. Prem Reddy Nursing Laboratory at CSUSB, and the Dr. Prem Reddy Lecture Hall at Western University of Health Sciences. [14]
Kallam Satish Reddy (son) G. V. Prasad (son-in-law) Kallam Anji Reddy (10 August 1941 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories , which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group ...
For premium support please call: 800-290-4726 more ways to reach us
About Dr. Reddy's Dr. Reddy's Laboratories Ltd. ( NYS: RDY ) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Dr. Reddy's Laboratories Limited (NSE:DRREDDY) with a market-capitalization of ₹432b, rarely draw ...
Kallam Satish Reddy is an Indian business executive and current Chairman of Dr. Reddy's Laboratories. [ 2 ] [ 3 ] Reddy joined Dr. Reddy's Laboratories in 1993 as executive director. Elevated to the role of Managing Director in 1997, he led the company's transition from a manufacturer of active pharmaceutical ingredients to one with a diverse ...
Benzex was later acquired by Dr. Reddy's Laboratories. He then left the industry to focus on construction. In 1990, he reemerged in pharmaceuticals and became the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr. Reddy's Laboratories [3] and Prasad took over as the vice-chairman and CEO of the merged entity. [4]